Tralokinumab - LEO Pharma
At a glance
- Drug Originator Cambridge Antibody Technology
- Drug Licenced by LEO Pharma
- Drug Class Anti-inflammatories; Antiasthmatics; Antifibrotics; Monoclonal antibodies; Skin disorder therapies
- Mechanism of Action Interleukin 13 inhibitors
- USA Patent Applicants LEO PHARMA AS
- USA Patents 9
- BLAs 1
- International Patents 113
Disclaimer